Associated tags: EHR, Map, Patient, Cancer, Genetic testing, Risk assessment, Breast cancer, Pharmaceutical industry, Nursing, Genetics, NCCN
Locations: UNITED STATES, NORTH AMERICA, NASHUA, NH, US, CHICAGO, ILLINOIS, LATIN AMERICA, NEW YORK, MASSACHUSETTS
Sociology,
University,
Providence St. Joseph Health,
Education,
Woman,
Henry Ford Health,
Pharmacy,
Falls,
Doctor of Philosophy,
Government,
Clover Health,
Alameda Health System,
Series,
Management,
Pharmaceutical industry,
Nursing CHICAGO, April 18, 2023 /PRNewswire-PRWeb/ -- CancerIQ, the platform powering early cancer detection and prevention across broad patient populations, today announced Carladenise Edwards, PhD, a dedicated leader with more than three decades of experience in healthcare, government and technology, as the newest member of its board of directors.
Key Points:
- CHICAGO, April 18, 2023 /PRNewswire-PRWeb/ -- CancerIQ , the platform powering early cancer detection and prevention across broad patient populations, today announced Carladenise Edwards, PhD, a dedicated leader with more than three decades of experience in healthcare, government and technology, as the newest member of its board of directors.
- "Carladenise's firsthand experience delivering results and exceeding growth targets for large health systems makes her an invaluable addition to CancerIQ's board," said Feyi Ayodele, CEO and co-founder of CancerIQ.
- Transitioning away from the health system C-suite, Dr. Edwards now serves as strategic advisor and board member for well-established healthcare companies such as Clover Health and Heluna Health.
- Dr. Edwards adds health system experience to a board already made up of members with diverse professional backgrounds, including experts in pharmacy, IT, investing, and life sciences.
High Risk,
Booth,
Cancer,
Risk assessment,
Risk,
NCCN,
Genetic counseling,
Magnetic resonance imaging,
Patient,
EHR,
Chemoprophylaxis,
Breast MRI,
HL7,
Conference,
Success,
Medical imaging,
Nursing CHICAGO, March 24, 2023 /PRNewswire-PRWeb/ -- CancerIQ will showcase its latest precision cancer prevention and early detection offerings for breast centers at the 32nd Annual Interdisciplinary Breast Center Conference (NCoBC 2023) in Las Vegas, March 24-28, (Booth #301). The company will offer NCoBC attendees an exclusive first look at two exciting new offerings: CancerIQ Complete, the industry's first full-service suite designed to help breast centers start, run and grow high-risk breast programs; and a new real-time, EHR-initiated CancerIQ Risk Calculator.
Key Points:
- The company will offer NCoBC attendees an exclusive first look at two exciting new offerings: CancerIQ Complete, the industry's first full-service suite designed to help breast centers start, run and grow high-risk breast programs; and a new real-time, EHR-initiated CancerIQ Risk Calculator.
- CancerIQ helps providers traverse the challenges of managing population-wide cancer risk assessment to offer more personalized, evidence-based care pathways that lead to early cancer detection and prevention.
- The new Risk Score Calculator brings comprehensive risk assessment into leading EHR workflows.
- CancerIQ is proudly sponsoring the High Risk IT Forum in the Pre-Conference High Risk Breast Program: Essentials for Success.
ROSEVILLE, Calif., May 22, 2019 /PRNewswire-PRWeb/ -- Adventist Health , a health system serving more than 80 communities on the West Coast and in Hawaii, today announced it is expanding its partnership with CancerIQ as part of a system-wide effort to reduce hereditary cancer deaths and improve population health.
Key Points:
- ROSEVILLE, Calif., May 22, 2019 /PRNewswire-PRWeb/ -- Adventist Health , a health system serving more than 80 communities on the West Coast and in Hawaii, today announced it is expanding its partnership with CancerIQ as part of a system-wide effort to reduce hereditary cancer deaths and improve population health.
- The CancerIQ cancer risk assessment and management platform will be integrated into the health system's Cerner Electronic Health Record (EHR) to streamline a multi-specialty rollout across the health system.
- These specialty groups offer enhanced cancer screening services such as breast MRI, and if appropriate perform preventive surgeries that can reduce cancer risk altogether.
- Adventist Health is a faith-based, nonprofit integrated health system serving more than 80 communities on the West Coast and Hawaii.
CHICAGO, March 22, 2019 /PRNewswire-PRWeb/ -- CancerIQ , a cancer risk assessment and management company, and AliveAndKickn , a Lynch Syndrome patient advocacy group, are partnering to help hospitals identify, educate and empower patients who have Lynch Syndrome.
Key Points:
- CHICAGO, March 22, 2019 /PRNewswire-PRWeb/ -- CancerIQ , a cancer risk assessment and management company, and AliveAndKickn , a Lynch Syndrome patient advocacy group, are partnering to help hospitals identify, educate and empower patients who have Lynch Syndrome.
- "Their wealth of resources will help providers who use the CancerIQ platform to identify more patients with Lynch Syndrome and reduce their risk."
- "So many patients are in the dark about Lynch Syndrome," said Robin Dubin, co-founder and Executive Director, AliveAndKickn.
- AliveAndKickn's mission is to improve the lives of individuals and families affected by Lynch Syndrome and associated cancers through research, education, and screening.
